Comparison of blood eosinophils and plasma periostin in stable and non-stable chronic obstructive pulmonary disease: How we can improve the management of our patients

Alizamin Sadigov (Baku, Azerbaijan), Alizamin Sadigov, Konul Abasaliyeva, Sakhvatdin Akhundov, Gunel Sadigova

Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Session: Biomarkers and phenotypes of COPD
Session type: Thematic Poster
Number: 3656
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Alizamin Sadigov (Baku, Azerbaijan), Alizamin Sadigov, Konul Abasaliyeva, Sakhvatdin Akhundov, Gunel Sadigova. Comparison of blood eosinophils and plasma periostin in stable and non-stable chronic obstructive pulmonary disease: How we can improve the management of our patients. Eur Respir J 2016; 48: Suppl. 60, 3656

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The characteristic of chronic renal dysfunction in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016


Relevance of hemoglobin A1c and acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013

The serum level of surfactantproteind in patients with chronic obstructive pulmonary disease, depending on the nutrtional status
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015


The role of biomarkers in predicting outcomes in acute exacerbations of chronic obstructive pulmonary disease (AECOPD)
Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU
Year: 2013


Factors associated with exacerbation in a general practitioners’-based Swiss chronic obstructive pulmonary disease (COPD) cohort
Source: Annual Congress 2013 –The best posters in chronic care
Year: 2013


Frequency of osteoporosis and pulmonary diffusing capacity in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – COPD: points to ponder
Year: 2014

The systemic inflammation and factors of coagulation in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – COPD markers
Year: 2014


Early phenotypes of chronic obstructive pulmonary disease (COPD)
Source: International Congress 2015 – Different data in COPD
Year: 2015

Elevated circulating CTLA-4 level in patients with COPD is related to systemic inflammation and disease severity
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013



Hyaluronic acid as a novel systemic biomarker to predict progression and severity in chronic obstructive pulmonary disease
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016

Increased heart rate modulation, sympathetic dominance and systemic inflammation in chronic obstructive pulmonary disease
Source: International Congress 2014 – Markers
Year: 2014

Detection of chronic obstructive pulmonary disease (COPD) in patients with cardio-vascular system pathology
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013


Comparison of the effects of smoking and biomass exposure in chronic obstructive pulmonary disease
Source: International Congress 2016 – Smoking-related diseases
Year: 2016


Influence of systemic inflammation and hypoxaemia on bone metabolism in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013


Relationships between C-reactive protein and disability in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2005 - Systemic effects of COPD
Year: 2005


Can we predict the outcomes of treatment of patients with severe exacerbation of chronic obstructive pulmonary disease (COPD)?
Source: Eur Respir J 2001; 18: Suppl. 33, 241s
Year: 2001

Association of the neutrophil-to-lymphocyte ratio with lung function and exacerbations in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Systemic biomarkers
Year: 2016

Clinical value of C-reactive protein in severe acute exacerbations of COPD
Source: Annual Congress 2005 - COPD - acute exacerbations
Year: 2005


Prediction of chronic renal failure in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – COPD: points to ponder
Year: 2014